Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Environmental and sociological factors shape sustainable entrepreneurial intentions among Pakistani university students. | Sci Rep | 2025 | 41214044 | PubTator, text mining | PubMed |
| Mitochondrial metabolism influences meiotic maturation in human oocytes of young and advanced maternal age women. | Hum Reprod | 2025 | 41206610 | PubTator, text mining | PubMed |
| Consumers' second-hand clothing purchase intention: integrating TPB, face consciousness and past purchase experience. | Front Psychol | 2025 | 41159165 | PubTator, text mining | PubMed |
| Integrating AI Literacy with the TPB-TAM Framework to Explore Chinese University Students' Adoption of Generative AI. | Behav Sci (Basel) | 2025 | 41153189 | PubTator, text mining | PubMed |
| Beyond the first purchase: unpacking the continuance intentions behind sustainable consumption. | Front Psychol | 2025 | 41143041 | PubTator, text mining | PubMed |
| Digital religion and Generation Z: an empirical study in the context of China. | Front Psychol | 2025 | 41112536 | PubTator, text mining | PubMed |
| Innate immunity of bile and cholangiocytes in primary biliary cholangitis. | Front Immunol | 2025 | 41112296 | PubTator, text mining | PubMed |
| S100a9 lactylation triggers neutrophil trafficking and cardiac inflammation in myocardial ischemia/reperfusion injury. | J Clin Invest | 2025 | 41066195 | PubTator, text mining | PubMed |
| Copper ionophore-autophagy interference nanoregulators for tumor self-defense reprograming to amplify cuproptotic stress and antitumor immunity. | J Control Release | 2025 | 41005744 | PubTator, text mining | PubMed |
| Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents? | Cells | 2025 | 41002413 | PubTator, text mining | PubMed |
| Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance. | Mol Cancer | 2025 | 40999456 | PubTator, text mining | PubMed |
| Analysis of technology acceptance and planned behavior of using shared E-biked to support the sustainable transportation development goal in smart cities. | Front Psychol | 2025 | 40978265 | PubTator, text mining | PubMed |
| Harnessing cuproptosis: a new avenue for targeted cancer therapies. | Apoptosis | 2025 | 40938523 | PubTator, text mining | PubMed |
| B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway. | World J Gastroenterol | 2025 | 40937457 | PubTator, text mining | PubMed |
| Comprehensive analysis of mitochondrial energy metabolism-related genes and immune infiltration in intervertebral disk degeneration. | Medicine (Baltimore) | 2025 | 40922310 | PubTator, text mining | PubMed |
| Determinants of fruit and vegetable consumption among Saudi adults: an extended Theory of Planned Behavior approach. | Front Public Health | 2025 | 40904927 | PubTator, text mining | PubMed |
| Copper ionophore complex ES-Cu synergizes with quercetin to target FDX1, promote cuproptosis, and reverse lenvatinib resistance in hepatocellular carcinoma cells. | J Adv Res | 2025 | 40902896 | PubTator, text mining | PubMed |
| SOX2 drives esophageal squamous carcinoma by reprogramming lipid metabolism and histone acetylation landscape. | Nat Commun | 2025 | 40897722 | PubTator, text mining | PubMed |
| A biomimetic nanoplatform for multimodal imaging-guided therapy of esophageal cancer via synergistic activation of cuproptosis and ferroptosis. | Mater Today Bio | 2025 | 40893372 | PubTator, text mining | PubMed |
| Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinoma. | Discov Oncol | 2025 | 40884619 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=10